p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!

The Journal of Pathology

Volumn 172, Issue 1, 1994, Pages 1-4

  Hall, Peter A ^a   Lane, David P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER; CONTROLLED STUDY; EDITORIAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TECHNIQUE; TUMOR SUPPRESSOR GENE;

EID: 0028299342     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711720103     Document Type: Editorial

References (23)

1. p53 in tumour pathology: can we trust immunohistochemistry?
2. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
3. Variations in immunohistochemical detection of p53 protein over‐expression in cervical tumours with different antibodies and methods of detection
4. p53: oncogene or anti‐oncogene?
5. The p53 tumour suppressor gene
6. Increased expression of mutant forms of p53 oncogene in primary lung cancer
7. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
8. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
9. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli
10. The E6 oncoprotein encoded by human papilloma virus type 16 and 18 promotes degradation of p53
11. The p53‐mdm2 autoregulatory feedback loop
12. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
13. Regulation of p53 expression in human breast cancer cell lines
14. UV irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells
15. High levels of p53 protein in UV irradiated normal human skin
16. Immunohistological detection of p53 in mammary carcinoma: an important new independent indicator of prognosis?
17. The relevance of antibody concentration to the immunohistological quantitation of cell proliferation associated antigens
18. p53 overexpression and Epstein Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas